Skip to main content
. 2022 Mar 19;39(5):2192–2207. doi: 10.1007/s12325-022-02105-5

Table 3.

Compared HYPO (severe and symptomatic) number per person between groups and at different time points, defined as: A = T−6/T0 (pre-randomization period); B = T0/T+6 (first follow-up period); C = T+6/T+12 (second follow-up period)

Groups HYPOs T−6/T0
(A = baseline)
Episode n
T0/T+6
(B period)
Episode n
T+6/T+12
(C period)
Episode n

Control group

(n. 359)

Severe n

Mean/person

89

1.61

72*

1.46

80

1.66

Symptomatic n

Mean/person

316

1.12

277*

1.22

311

1.08

Total 405 349 391

Intervention group

(n. 359)

Severe n

Mean/person

91

1.56

38**

1.52

12***&&

2.10

Symptomatic n

Mean/person

308

1.10

59**

1.73

25***&&

2.27

Total 399 97 37

B vs. A: *p < 0.05; **p < 0.01: ***p < 0.001; C vs. A: && p < 0.01